Nami Pandit- Abid, n/a

US Medical Franchise Head
Sanofi, Bridgewater, NJ, USA

Poster(s):

• (410) Baseline Characteristics of Patients on Medium-Versus High-Dose Inhaled Corticosteroids in Patients Initiating Dupilumab in a Real-World Clinical Setting: The RAPID Registry
  Wednesday, October 29, 2025